MENU
+Compare
BRNS
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$0.92
Change
-$0.00 (-0.00%)
Capitalization
36.95M

BRNS Barinthus Biotherapeutics plc Forecast, Technical & Fundamental Analysis

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer... Show more

BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BRNS with price predictions
Jun 27, 2025

Momentum Indicator for BRNS turns positive, indicating new upward trend

BRNS saw its Momentum Indicator move above the 0 level on June 27, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where BRNS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

BRNS moved above its 50-day moving average on June 26, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BRNS turned negative on June 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for BRNS crossed bearishly below the 50-day moving average on June 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRNS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BRNS broke above its upper Bollinger Band on May 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BRNS entered a downward trend on June 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.320) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). BRNS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (2.431) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BRNS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BRNS is expected to report earnings to fall 27.20% to -35 cents per share on August 07

Barinthus Biotherapeutics plc BRNS Stock Earnings Reports
Q2'25
Est.
$-0.36
Q1'25
Missed
by $0.13
Q4'24
Missed
by $0.05
Q3'24
Beat
by $0.23
Q2'24
Missed
by $0.03
The last earnings report on May 07 showed earnings per share of -49 cents, missing the estimate of -36 cents. With 2.91K shares outstanding, the current market capitalization sits at 36.95M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Unit 6-10, Rutherford Avenue
Phone
+44 1865818808
Employees
98
Web
https://www.barinthusbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BSX106.531.95
+1.86%
Boston Scientific Corp
LEGT10.68N/A
N/A
Legato Merger Corp
STBA38.01-0.20
-0.52%
S&T Bancorp
VAL41.86-0.29
-0.69%
Valaris Limited
RVP0.62-0.04
-6.27%
Retractable Technologies

BRNS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with NGNE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
N/A
NGNE - BRNS
51%
Loosely correlated
-2.47%
NRIX - BRNS
32%
Poorly correlated
+0.17%
ASBP - BRNS
26%
Poorly correlated
-7.03%
CRNX - BRNS
25%
Poorly correlated
-0.10%
SLN - BRNS
25%
Poorly correlated
+4.51%
More